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ABSTRACT
Introduction: Genetic education and counseling give individuals an opportunity to make informed choices related to risks, 
benefits, and limitations of genetic testing for social and medical purposes. We aimed to assess the perception of female 
undergraduates of universities in Ibadan to genetic counseling and testing (GCT) for gynecological cancers and their 
willingness to participate in the twin procedure.
Materials and Methods: This was a cross-sectional study involving consented female students from the two universities 
within Ibadan metropolis – University of Ibadan and Lead City University, Ibadan. Using a self-administered, semi-structured 
questionnaire, information on their understanding of GCT, perception of implications, and willingness to participate in the 
procedure were obtained.
Results: There were 943 respondents with mean age of 20.0 ± 3.4 years, 908 (96.3%) had ever heard of cancers, but only 
252 (26.7%) provided proper definition. Overall, 484 (51.3%) were aware of GCT although three‑quarters, 712 (75.5%), 
wished to know their inheritable risk of developing gynecologic cancer. All the respondents were willing to participate in the 
counseling procedure, but only 815 (86.4%) would be willing to proceed with testing if indicated. Possible surgical intervention 
reduced willingness to test from 82.3% to 45.7%.
Conclusion: The female undergraduates of universities in Ibadan were willing to partake in GCT provided there are no 
surgical interventions. There is a need for an increased awareness and encouragement of GCT for at-risk groups and also in 
the prevention and/or early detection to reduce the burden of familial gynecologic cancers.
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Introduction
The incidence of gynecologic cancers has been growing in 
recent years along with the related mortality rates.[1] Genetic 
risk assessment, counseling, and testing is generally a multistep 
process involving identification of individuals who may be at 
increased risk for potentially harmful mutations, followed 
by genetic counseling from suitably trained health-care 
providers and genetic testing of selected high-risk individuals 
as indicated. Most familial gynecologic cancers tend to occur 
in younger age groups compared to similar sporadic cases.
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Although the causes of gynecologic cancers are not fully 
understood, the genetics of hereditary gynecologic cancers are 
continually evolving, and our understanding of the molecular 
basis of inherited susceptibility to gynecologic cancers has 
improved considerably.[2] Factors such as family history, 
genetic predisposition, risky sexual behavior, viral infections 
such as human papillomavirus, early menarche and coitarche, 
parity, and in utero exposure to diethylstilbestrol are among 
the many risk factors screened for although it is now noted 
that identifying mutation carriers has important implications 
for management, long-term surveillance, and risk reduction 
of gynecologic cancers. In addition, at-risk relatives can be 
offered testing and appropriate risk management if found to 
be mutation carriers or reassured if not. Gynecologists and 
gynecologic oncologists have major roles to play in not only 
identifying women at risk of inherited cancer syndromes 
and referring such patients to genetic services but also in 
managing them appropriately.[1,3] It has been documented that 
women with germ line mutations in the cancer susceptibility 
genes, BRCA1 and/or BRCA2, associated with hereditary breast 
and ovarian cancer syndrome have up to an 85% lifetime risk 
of breast cancer and up to a 46% lifetime risk of ovarian, tubal, 
and peritoneal cancers.[4]
Genetic counseling has been described by the National 
Society of Genetic Counselors as the process of helping 
people understand and adapt to the medical, psychological, 
and familial implications of genetic contributions to 
disease.[5] Individuals are considered to be candidates 
for cancer risk assessment if they have a personal and/or 
family history (maternal lineage) with features suggestive 
of hereditary cancers.[6] Such candidates for genetic testing 
receive genetic education and counseling before testing 
to facilitate informed decision-making and adaptation to 
the risk or condition. On the other hand, genetic testing is 
recommended or offered when a risk assessment suggests 
the presence of an inherited cancer syndrome for which 
specific genes have been identified.[7] Pertinent conditions 
for offering the test include: (1) an individual has a personal 
or family history suggestive of a genetic cancer susceptibility 
syndrome, (2) the result of the test can be interpreted, and (3) 
testing will influence medical management. In general, 
genetic testing is performed when there is evidence of an 
inherited susceptibility that had neither been tested nor had 
identifiable mutation and also in families with a documented 
deleterious mutation.[7-10] Genetic counseling increases 
the accuracy of risk perception, decreases intention for 
mutation testing among women who are unlikely carriers, 
and decreases cancer-related worry, anxiety, and depression.[7]
Genetic testing has the potential to provide information about 
cancer risk, thereby significantly contributing to measures 
of cancer prevention.[1] However, genetic testing raises a lot 
of ethical issues as it is only ethical and useful if combined 
with counseling and implementation of risk management 
strategies. Cancer prevention and screening practices have been 
documented to improve outcome greatly among women at risk 
for hereditary breast and ovarian cancer after genetic counseling 
in the community setting.[11-14] The main thrusts of this study 
were to assess the perception of female undergraduates of 
universities in Ibadan about genetic counseling and testing (GCT) 
for gynecological cancers, determine their willingness to be 
counseled and tested for inherited traits of some gynecological 
cancers, and assess their willingness to undertake any necessary 
preventive strategy that may be advised.
Materials and Methods
This study was conducted among selected, consenting 
full-time undergraduate students of the two universities 
within Ibadan metropolis – the University of Ibadan and the 
Lead City University, Ibadan. Using convenience sampling 
technique, a semi-structured, self-administered questionnaire 
was used to obtain necessary data. The questionnaire 
consisted of sections on the respondents’ sociodemographic 
characteristics, knowledge about gynecologic cancers, 
awareness of the risk factors for gynecologic cancers, 
perception on GCT for cancers, and willingness to be tested.
Confidentiality and anonymity of the participants were 
ensured as the questionnaires lacked means of identification 
and thus cannot be traced. The study was adequately 
explained to respondents, and informed consent obtained 
before administering the questionnaire. In addition, 
participation was voluntary and data obtained were treated 
with confidentiality. The data collected were cleaned, coded, 
and entered into the computer. Analysis was done using 
the Statistical Package for the Social Sciences version 20.0 
(SPSS Inc, Chicago IL, USA). Data were presented using 
frequency distribution, percentages, and charts.
Results
A total of 943 consenting female undergraduates satisfactorily 
responded to the survey. The mean age of the respondents 
was 20.0 ± 3.4 years; about two-fifths, 380 (40.3%), were in 
their 1st year of study while single women were 906 (96.1%). 
Other sociodemographic characteristics are presented in 
Table 1. The majority, 908 (96.3%), of them had heard about 
cancers before this study although only 252 (26.7%) properly 
understood what cancer meant [Figure 1].
Most of the respondents were aware of breast (86%), 
cervical (82.6%), and ovarian (63%) cancers with the 
Oluwasola and Odukogbe: Genetic counseling for gynecologic cancers in Nigeria
197Tropical Journal of Obstetrics and Gynaecology / Volume 34 / Issue 3 / September‑December 2017
main sources of information being media (67.7%) and 
internet (60.9%) [Table 2]. The perception of the respondents 
about the risk factors for gynecologic cancers is presented in 
Table 3 while their awareness of various gynecologic cancers 
is presented in Figure 2. Overall, almost half, 431 (45.7%), of 
our respondents have relations and friends who have been 
previously diagnosed with cancers, especially breast (49.4%) 
and gynecological cancers (15.7%), while 484 (51.3%) 
were aware of both GCT and additional two people were 
aware of counseling alone. Only two-thirds, 595 (63.1%), 
of our respondents thought that cancers can be prevented 
generally [Figure 3] while 11.6% were of the opinion that 
cancers were mere superstitious beliefs [Table 3].
The attitude toward GCT was good in 644 (68.3%) of the 
respondents while 877 (93%) of them agreed that it should 
be encouraged, especially among the at-risk group, and 
715 (75.8%) believed that the procedure will result in a more 
favorable outcome in terms of survival from gynecologic 
cancers. About three-quarters, 712 (75.5%), wished to 
know their personal risk of developing gynecologic cancers 
[Table 1]. When the possibility of psychological and emotional 
disturbance of knowing one’s susceptibility to developing 
gynecologic cancers was mentioned, 696 (73.8%) believed that 
this would have an insignificant negative effect on willingness. 
All our respondents were willing to have genetic counseling for 
gynecologic cancers, but 13.6% opted out of possible follow-up 
genetic testing if indicated.
The following factors were identified as positively affecting 
the willingness of the respondents to accept GCT: knowing 
other available measures of treatment of the cancers (68.3%), 
knowing the risks associated with the cancers (67%), 
making the testing free (64.1%), and past experience 
with cancer survivors (63.3%). On the other hand, fear of 
the unknown (63.9%) and emotional disturbance (61.7%) 
will have negative effect on acceptance of the procedure 
while 355 (37.6%) said that they were not convinced of its 
necessity [Table 4].
In the absence of surgery, 776 (82.3%) of our respondents 
are willing to have necessary intervention, but this number 
reduced by almost half when willingness for surgical 
intervention was assessed (from 82.3% to 45.7%). This 
reduction was mostly attributed to fear (58.0%) and religious 
beliefs (36.0%) about surgeries generally.
Discussion
Genetic testing may enable targeted surveillance, effective 








Mean age (years) 20.0±3.4
Level of study
100 level 380 (40.3)
200 level 185 (19.6)
300 level 157 (16.6)
400 level 164 (17.4)
500 level 21 (2.2)




Ever heard of cancer
Yes 908 (96.3)
No 35 (3.7)
Ever heard of genetic counseling and testing
Yes 484 (51.3)
No 459 (48.7)




Willing to know about personal risk for cancer
Yes 712 (75.5)
No 231 (24.5)
Willingness to have necessary intervention
Yes 776 (82.3)
No 167 (17.7)
Willingness to have surgical intervention
Yes 431 (45.7)
No 512 (54.3)
Will recommend genetic counseling to others
Yes 857 (90.9)
No 86 (9.1)
Figure 1: Pie chart showing the percentage of respondents that properly 
defined cancers
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prevention strategies, early disease detection, and treatment 
of localized cancer cases with the possibility of cure or 
long-term survival. Knowledge of risk enables behavioral 
change as it has been stated that specific cognitive and 
motivational factors appear to influence risk perception.[15] 
Despite limited knowledge, a high interest level in genetic 
testing has been reported among high-risk African–American 
women with cultural beliefs and values influencing genetic 
testing decisions.[16,17] A study reported in 1999 by Durfy 
et al.[15] showed that women favored ready access to testing, 
believed decision to be tested should be a personal choice, 
believed that genetic results should stay confidential, and 
were not greatly concerned that all these might be impossible.
In comparison with the findings of Jedy-Agba et al. in 
2012[18] that awareness levels about breast and cervical 
cancers were the most common among women, our study 
also found this trend to apply among the study population. 
However, the awareness about the risk factors associated 
with gynecologic cancers was poor, thus calling for attention 
on information dissemination about these cancers. Majority 
of our respondents were willing to know their personal 
risk of developing gynecologic cancers unlike in a similar, 
but hospital-based study conducted by Dekker et al., 2007, 
among patients with gynecologic cancers where 36% and 
63% of patients with endometrial and ovarian cancers, 
respectively, accepted genetic counseling mainly to receive 
risk assessment for themselves and relatives.[19] Moreover, 
most of our respondents also believed that GCT should be 
encouraged despite the potential psychological and emotional 
disturbance of knowing one’s possibility of developing one 
or more gynecologic cancers. Our study also corroborated 
previous reports that GCT, if widely accepted and properly 
done, have the chance of offering better prevention and early 
diagnosis of inheritable gynecologic cancers.[8,19]
Majority of the respondents indicated willingness to 
participate in GCT if given the opportunity and were willing 
to have necessary intervention if found to be at risk. However, 
and rather interestingly, this number dropped by almost 50% 
if the intervention involves surgery. This reduction resulted 
from the fear of being unsure of the possible outcomes 
of such intervention including having to lose body parts, 
religious beliefs and the fact that as yet, there is no cure for 
Table 3: Perceived risk factors for gynecologic cancers
Variable Frequency (%)
Early age at menarche
Yes 186 (19.7)
No 757 (80.3)
Early age at coitarche
Yes 465 (49.3)
No 478 (50.7)
























Table 2: Sources of information on gynecologic cancers*









Figure 2: Bar chart showing the awareness of various types of gynecological 
cancers (in percentages)
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cancers. This is similar to a report by TM Wagner et al.[20] 
when the attitude toward prophylactic surgery and effects 
of genetic counseling in families with BRCA mutations were 
assessed. The report showed that prophylactic mastectomy 
was considered by only 21% of the mutation carriers while 
the majority of affected and nonaffected carriers expected 
prophylactic mastectomy to impair their quality of lives such 
that only 50% of carriers agreed to undergo prophylactic 
oophorectomy instead.[20]
Most of our respondents were unfamiliar with risk factors 
for gynecological cancers which are similar to an earlier 
report by Sule and Shehu that only 9.7% of patients in 
developing countries knew that unusual vaginal discharge or 
abnormal bleeding could be early symptoms of gynecologic 
malignancies.[21] In a systematic review of perceived risks, 
Heshka et al. also reported that younger women were less 
aware of risk factors such as early coitarche, multiple sexual 
partners, and high parity although they were more informed 
about gynecologic malignancies contrary to earlier reports.[8] 
Knowledge of methods of early detection was very low among 
our respondents, and only 50% agreed that cancer is curable 
when detected early, thus highlighting a considerable level of 
ignorance and lack of awareness of cancer among the study 
population of university undergraduates.
This lack of awareness is principally due to inadequate 
dissemination of information. It is, however, established 
that most people favor GCT in our environment despite 
the psychological effects of a possible positive result. 
Therefore, it is important to note that performing GCT 
requires individuals with expertise in cancer genetics, 
sufficient ability to adequately counsel patients pre- and 
post-test to encourage possible risk reduction strategies, 
and reduce the potential psychological impact of the test 
results. Potential benefits of increased opportunities for and 
access to screening programs including GCT are enormous 
and should be explored by developing countries.
Conclusion
Most female undergraduates of universities in Ibadan were 
willing to participate in GCT provided there are no surgeries 
involved. There is a need for an increased awareness 
and encouragement of GCT for at-risk groups and also in 
prevention and/or early detection to reduce the burden of 
familial gynecologic cancers. There is an urgent need for 
processes that will foster an increased awareness of GCT 
and its benefits.
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